InspireMD Q4 EPS $(0.16) Beats $(0.20) Estimate, Sales $1.76M Beat $1.63M Estimate

Author: Benzinga Newsdesk | March 06, 2024 08:01am
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 73.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $1.76 million which beat the analyst consensus estimate of $1.63 million by 8.04 percent. This is a 71.64 percent increase over sales of $1.03 million the same period last year.

Posted In: NSPR